Eikon Therapeutics, Inc. (NASDAQ: EIKN) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT EIKON THERAPEUTICS, INC.

Eikon Therapeutics, Inc. (NASDAQ: EIKN)
Listen to this Section


$8.88
-0.8970 ( -9.17% ) 123.5K

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Market Data


Open $8.88
Previous Close $9.78
Volume 123.5K
Market Cap $529.48M
Day Range $8.87 - $9.92
52 Week Range $7.90 - $17.40
Shares Outstanding 54.14M
Change % -9.17%
Net Change ▼ -0.8970
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
IPO Year2026
CountryUnited States
UnderwriterJ.P. Morgan, Morgan Stanley, BofA Securities, Cantor Fitzgerald, Mizuho Securities, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


No data available for selected period.

Latest News


× Before browsing our site, please accept our cookies policy